HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials

MLA

Alfred E. Buxton, et al. “HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials.” Journal of the American College of Cardiology, vol. 64, no. 11, Sept. 2014, pp. 1143–77. EBSCOhost, https://doi.org/10.1016/j.jacc.2014.04.008.

APA

Alfred E. Buxton, Fred Kusumoto, Mandeep R. Mehra, Lynne Warner Stevenson, Stefan H. Hohnloser, Mina K. Chung, Lisa Welikovitch, Richard Lee, John P. Boehmer, Venu Menon, David J. Slotwiner, Hugh Calkins, Paul D. Varosy, Michael R. Gold, Win Kuang Shen, Julia H. Indik, & Richard L. Page. (2014). HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials. Journal of the American College of Cardiology, 64(11), 1143–1177. https://doi.org/10.1016/j.jacc.2014.04.008

Chicago

Alfred E. Buxton, Fred Kusumoto, Mandeep R. Mehra, Lynne Warner Stevenson, Stefan H. Hohnloser, Mina K. Chung, Lisa Welikovitch, et al. 2014. “HRS/ACC/AHA Expert Consensus Statement on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials.” Journal of the American College of Cardiology 64 (11): 1143–77. doi:10.1016/j.jacc.2014.04.008.